Submitting Next-Generation Sequencing Data to the Division of Antiviral Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 1, 2026
July 1, 2026
5f623ca9-5f9b-4728-b634-4e46ac31856c
Related Documents
Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
Guidance DocumentOctober 20, 2026Center for Drug Evaluation and Research
Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug
Guidance DocumentJune 18, 2026Center for Drug Evaluation and Research
Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals
Guidance DocumentMay 1, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.